Search
Studio
Logo
Log In
Research
  • Home
  • Posts
  • ๐Ÿ“Š Research: From Record To Rout

๐Ÿ“Š Research: From Record To Rout

The energy tail risk no oneโ€™s talking about, why a retail giant got double-downgraded, a candidate for the next IPO pop, and more.

Brooks Dyroff
Casimir Stone
Brooks Dyroff & Casimir Stone

Nov 15, 2025

Keep Reading

๐Ÿ“Š Research: A Rainbow Behind the Cloud
LockSimple

Apr 18, 2026

โ€ข

1 min read

๐Ÿ“Š Research: A Rainbow Behind the Cloud

Plus, a Permian Basin play that just got a 73% PT bump, a GPCR drug developer with 60% upside potential, and more...

Brooks Dyroff
Casimir Stone
Brooks Dyroff, +1
๐Ÿ“Š Research: Working the Oracle
LockSimple

Apr 11, 2026

โ€ข

2 min read

๐Ÿ“Š Research: Working the Oracle

Plus, a precision oncology biotech with room to run, a CNS drug challenger with nearly $4B in projected peak sales, and more...

Brooks Dyroff
Casimir Stone
Brooks Dyroff, +1
๐Ÿ“Š Silver Lining
LockSimple

Apr 4, 2026

โ€ข

2 min read

๐Ÿ“Š Silver Lining

Plus, a top-1% analyst's highest-conviction AI infrastructure bet and the post-IPO software name Goldman says the market is missing out on.

Brooks Dyroff
Casimir Stone
Brooks Dyroff, +1